Patents by Inventor George Minno

George Minno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11918573
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: March 5, 2024
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11617749
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: April 4, 2023
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Choline Esters
    Publication number: 20220151988
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: February 4, 2022
    Publication date: May 19, 2022
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20210290617
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 23, 2021
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
    Publication number: 20210177807
    Abstract: Methods of treating eyelid swelling in a subject comprising administering to the ocular surface of the subject an effective amount of glycerol and naphazoline. The glycerol can be present at a concentration of about 7.5% w/v and the naphazoline can be present at a concentration of about 0.01% to about 0.5% w/v. The compositions do not comprise an antihistamine.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 17, 2021
    Inventors: Matthew Jonathan CHAPIN, Mark Barry ABELSON, Keith Jeffrey LANE, George MINNO
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10987352
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: April 27, 2021
    Assignee: NICOX OPHTHALMICS, INC
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20200405711
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: September 11, 2020
    Publication date: December 31, 2020
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • Choline Esters
    Publication number: 20200352903
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: February 14, 2020
    Publication date: November 12, 2020
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20200297719
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: April 3, 2020
    Publication date: September 24, 2020
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10675279
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: June 9, 2020
    Assignee: NICOX OPTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20180280383
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: June 6, 2018
    Publication date: October 4, 2018
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • Choline Esters
    Publication number: 20180228767
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: December 11, 2017
    Publication date: August 16, 2018
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • Method of treating presbyopia using dithiol compounds and their derivatives
    Patent number: 10039743
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: August 7, 2018
    Assignee: NOVARTIS AG
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9993471
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: June 12, 2018
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9750684
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: September 5, 2017
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • DITHIOL COMPOUNDS, DERIVATIVES, AND USES THEREFOR
    Publication number: 20170231951
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: December 20, 2016
    Publication date: August 17, 2017
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20170182035
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
    Publication number: 20170079957
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconsgtrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Inventors: Matthew Jonathan Chapin, Mark Barry Abelson, Keith Jeffrey Lane, George Minno
  • Dithiol compounds, derivatives, and uses therefor
    Patent number: 9567314
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: February 14, 2017
    Assignee: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Choline Esters
    Publication number: 20160287557
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: April 5, 2016
    Publication date: October 6, 2016
    Inventors: William GARNER, Margaret Garner, George Minno, David Gooden